Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4330 Py-itc Novel suppressor of cancerous cell growth and proliferation
DCC4331 Pyochelin Bacterial siderophore, acting as an iron-chelating growth promoter for Pseudomonas aeruginosa
DCC4332 pyranoxanthone 1 Novel inhibitor of p53-MDM2 interaction
DCC4333 Pyrd-in-14 Novel inhibitor of the PyrD protein (a dihydroorotate dehydrogenase (DHODase) involved in pyrimidine biosynthesis), suppressing bacterial cytotoxicity, biofilm formation and antibiotic resistance
DCC4334 Pyrenocine A Natural phytotoxin, inducing monopolar spindle formation and suppressing proliferation of cancer cells
DCC4335 Pyridinone-14 Novel highly potent agonist of the apelin receptor (APJ) receptor (APJ cAMP EC50: human 0.023nM; rat 0.024nM; dog 0.030nM; monkey 0.080nM)
DCC4336 Pyrithione Zinc Novel KMD5A inhibitor
DCC4337 Pysoca Substrate-1 Novel BBB-permeable substrate of pyrilamine-sensitive proton-coupled organic cation antiporter (PYSOCA), acting as a selective class I HDAC inhibitor
DCC4338 Pyy3-36 Y2/Y5 Neuropeptide Y receptor agonist, reducing food intake in normal-weight and obese individuals and the plasma levels of the hunger-promoting hormone ghrelin
DCC4339 Pz-1444 Novel inverse agonist of 5-HT6 receptor
DCC4340 Q8pnap Novel class of bright near infrared window II (NIR-II, 1,000 - 1,700 nm) probe, being successfully used to achieve high spatial and temporal resolution imaging of hind limb vasculature, lymphatic system, and small tumor metastasis, as well as precise NIR-
DCC4341 q94 Hydrochloride Selective PAR1 negative allosteric modulator
DCC4342 Qc-308 Hydrochloride Novel Heme Oxygenase-1 Inhibitor (HO-1 IC 50 =0.27μM; HO-2 IC 50 =0.46μM)
DCC4343 Qd394-me Novel reactive oxygen species (ROS) inducer, showing significant cytotoxicity in pancreatic cancer cells
DCC4344 Qls-81 Novel Nav1.7 channel blocker (IC 50 at 3.5±1.5 μM). being efficacious on chronic pain in mice
DCC4345 Qndesa Novel fluorescent molecular rotor for the selective detection of the hybrid-conformation 22AG G-Quadruplex
DCC4346 Qs Inhibitor 1 Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus
DCC4347 Qs Inhibitor 2 Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus
DCC4348 Qtc-4-meobne Novel multitarget anti-AD agent, significantly increasing in adult neurogenesis and remyelination through Prox1/NeuroD1 and Wnt/β-catenin pathways, demonstrating beneficial effects in preclinical models of AD
DCC4349 Quatcy-i2 Novel photodynamic antitumor agent
DCC4350 Quazepam Modulator of specific GABAA receptors via the benzodiazepine site on the GABAA receptor
DCC4351 Quilseconazole Besylate Potent, orally active fungal Cyp51 (lanosterol 14-α-demethylase) inhibitor
DCC4352 Quinine Sulfate Natural disrupter of DNA replication and transcription via DNA intercalation, reducing oxygen intake and carbohydrate metabolism and the excitability of muscle fibers, inhibiting the drug efflux pump P-glycoprotein
DCC4353 Quoromycin Novel antivirulence agent against Vibrio vulnificus, inhibiting the quorum-sensing signaling pathway by controlling the DNA-binding affinity of SmcR and thus effectively alleviating the virulence of V. vulnificus in vitro and in vivo
DCC4354 Qw-296 Novel microtubule destabilizer
DCC4355 R-(+)-eu-1180-453 Second-Generation GluN2C- and GluN2D-selective positive allosteric modulator (PAM) of the N-methyl-d-aspartate (NMDA) receptor
DCC4356 R(ccug) Ligand 63 Novel Potent and Specific Ligand of r(CCUG)exp, Targeting r(CCUG) Repeats in Myotonic Dystrophy Type 2, Facilitating Degradation by RNA Quality Control Pathways
DCC4357 r-138329 Novel scavenger receptor class B type I blocker
DCC4358 r-154716 Novel inhibitor of HDL uptake induced by overexpression of scavenger receptor BI (SR-BI)
DCC4359 R523062 Novel Antiviral agent for Enterovirus D68

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>